Genzyme Corporation FDA Inspection Record

FEI 1221955 · Inspections, Form 483s, warning letters and import refusals

Genzyme Corporation is an FDA-inspected facility (FEI 1221955) located in Cambridge, MA, US. RegDataLab tracks 9 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Aug 10, 2016: No Action Indicated (NAI)
Inspections on record
9 (4 VAI, 5 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
4, latest Feb 16, 2016
Import refusals
1

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Aug 10, 2016No Action Indicated (NAI)No citations listed
Aug 22, 2014No Action Indicated (NAI)No citations listed
Mar 25, 2014No Action Indicated (NAI)No citations listed
Sep 30, 2013Voluntary Action Indicated (VAI)No citations listed
Oct 5, 2012No Action Indicated (NAI)No citations listed
Jun 28, 2011Voluntary Action Indicated (VAI)Test methods (21 CFR 211.165(e))
Investigations of discrepancies, failures (21 CFR 211.192)
Jun 2, 2010Voluntary Action Indicated (VAI)Late submission of 15-day report (21 CFR 314.80(c)(1)(i))
Submission of report follow-up (21 CFR 314.80(c)(1)(ii))
Failure by applicant to report ADE (21 CFR 314.80(c))
Late submission of annual safety reports (21 CFR 314.80(c)(2))
and 1 more
Sep 9, 2009No Action Indicated (NAI)No citations listed
Oct 20, 2008Voluntary Action Indicated (VAI)Investigator non-compliance (21 CFR 312.56(b))
General responsibilities of sponsors (21 CFR 312.50)

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Feb 16, 2016Class IID-0729-2016Thyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For… and 1 more product
Presence of Particulate Matter: Glass particles found in the product after reconstitution.
Dec 8, 2015Class IIID-0799-2016Lumizyme (alglucosidase alpha), 50 mg/vial, For Intravenous Infusion Only, Rx Only…
Labeling: Incorrect or Missing Lot and/or Exp Date
Mar 24, 2014Class IIIB-0992-14Genzyme Thymoglobulin¿ [Anti-thymocyte Globulin (Rabbit)], 25 mg (NDC 58468-0080-01)
Anti-Thymocyte Globulin (Rabbit) 25 mg, with a trend approaching the upper limit on the molecular size distribution tests for polymers…
Jan 31, 2012Class IID-1203-2012FLUDARA (fludarabine phosphate) for injection, 50 mg, Single Dose Vial, For Intravenous…
Lack of assurance of sterility: Based on joint FDA/EMA inspection conducted at the manufacturer Ben Venue Laboratories in Bedford, Ohio, in…

FDA record score

0 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 22, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

6 records behind this number
RecordDatePoints x age weightAdds
Class II recall D-0729-2016, this FEI as the recalling firmFeb 16, 201610 years or older, so it adds no points0
Inspection classified VAISep 30, 201310 years or older, so it adds no points0
Class II recall D-1203-2012, this FEI as the recalling firmJan 31, 201210 years or older, so it adds no points0
Inspection classified VAIJun 28, 201110 years or older, so it adds no points0
Inspection classified VAIJun 2, 201010 years or older, so it adds no points0
Inspection classified VAIOct 20, 200810 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 22, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 22, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 22, 2026Newest record Nov 13, 2026Current
Warning letter textNov 22, 2026Newest record Nov 17, 2026Current
Recalls (Enforcement Report)Nov 22, 2026Newest record Nov 18, 2026Current
Form 483s and inspection documentsNov 18, 2026Newest record Nov 17, 2026Current
Import refusalsNov 22, 2026Newest record Nov 12, 2026Current

Reviewing Genzyme Corporation as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Genzyme Corporation yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Genzyme Corporation
Location
Cambridge, MA (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.